SCHEMBL19699322

SCHEMBL19699322

COc1cc(C=O)ccc1C(=O)OC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.53
TSHR P16473 1/20 0.53
HPGD P15428 2/20 0.53
TRIM24 O15164 1/20 0.53
ALDH5A1 P51649 1/20 0.53
ABAT P80404 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
TRIM33 Q9UPN9 1/20 0.53
AOX1 Q06278 1/20 0.49
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP1A2 P05177 1/20 0.48
HSP90AA1 P07900 1/20 0.48
CYP2C19 P33261 1/20 0.48
POLB P06746 1/20 0.48
KDM4E B2RXH2 2/20 0.47
FDPS P14324 1/20 0.46
ALDH1A3 P47895 1/20 0.46
TTR P02766 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30394977 0.89 ALDH1A1 (0.54) ALDH1A1TSHRHPGDTRIM24ALDH5A1
SCHEMBL6504372 0.89 ALDH1A1 (0.54) ALDH1A1TSHRHPGDTRIM24ALDH5A1
SCHEMBL359439 0.84 ALDH1A1 (0.63) ALDH1A1TSHRHPGDTRIM24ALDH5A1
SCHEMBL3595801 0.83 ALDH1A1 (0.40) ALDH1A1TSHRHPGDTRIM24ALDH5A1
SCHEMBL27980562 0.81 ALDH1A1 (0.47) ALDH1A1HPGDTRIM24ALDH5A1ABAT
SCHEMBL360471 0.81 ALDH1A1 (0.42) ALDH1A1TSHRHPGDTRIM24ALDH5A1
SCHEMBL5472079 0.81 ALDH1A1 (0.44) ALDH1A1TSHRHPGDTRIM24ALDH5A1
SCHEMBL19695468 0.80 HPGD (0.48) ALDH1A1TSHRHPGDTRIM24ALDH5A1
SCHEMBL20379139 0.80 ALDH1A1 (0.41) ALDH1A1TSHRHPGDTRIM24ALDH5A1
SCHEMBL15878940 0.80 ALDH1A3 (0.40) ALDH1A1TSHRHPGDTRIM24ALDH5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10669242-B2 Clostridium difficile toxin inhibitors Venenum Biodesign, LLC (US) 2020-06-02 US disclosed
US-20190194147-A1 Novel Clostridium Difficile Toxin Inhibitors Venenum Biodesign, LLC (US) 2019-06-27 US disclosed
WO-2017214359-A1 NOVEL CLOSTRIDIUM DIFFICILE TOXIN INHIBITORS VENENUM BIODESIGN LLC (US) 2017-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194147-A1 Novel Clostridium Difficile Toxin Inhibitors GABRA5, GABRA1, GABRA4 ALDH1A1 2381/4885TSHR 1711/4885HPGD 1793/4885
US-10669242-B2 Clostridium difficile toxin inhibitors GABRA5, GABRA1, GABBR2 ALDH1A1 1908/4885TSHR 1362/4885HPGD 1448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.